Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01412710 · ClinicalTrials.gov registry record · NA

Vitamin D Supplementation on Cardiovascular Risk Factors

A NA study of Type 2 Diabetes, sponsored by Florida International University.

Completed
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT01412710 is a NA study of Type 2 Diabetes that has completed, run by Florida International University. The registered enrollment target is 92 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01412710, a NA study of Type 2 Diabetes, has completed, sponsored by Florida International University.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

The purpose of the present pilot study is to determine the effect of vitamin D supplementation (4000 IU or 6000 IU once daily for 6 months) on reducing heart disease risk and in improving blood glucose control in type 2 Diabetes subjects . The investigators are working with Hispanics and African Americans living in Miami, Florida.

Conditions Studied

Interventions

  • DRUG Cholecalciferol

Study Locations (1)

Florida

  • Human Nutrition Laboratory, Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2011-07
Est. Completion 2013-09
Phase NA

Sponsor

Florida International University

89 total trials

What the Registry Record Tells You About NCT01412710

The ClinicalTrials.gov registry entry for NCT01412710 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Cholecalciferol is the first listed.

NCT01412710 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01412710 about?

NCT01412710 is a clinical study titled "Vitamin D Supplementation on Cardiovascular Risk Factors". The purpose of the present pilot study is to determine the effect of vitamin D supplementation (4000 IU or 6000 IU once daily for 6 months) on reducing heart disease risk and in improving blood glucose control in type 2 Diabetes subjects . The investigators are working with Hispanics and African Ame...

What is the current status of trial NCT01412710?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2011-07. Estimated completion is 2013-09.

What conditions does trial NCT01412710 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT01412710?

The interventions under investigation include: Cholecalciferol (DRUG).

Who is sponsoring clinical trial NCT01412710?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01412710 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.